Back
Biomarin Pharmaceutical Stock Price Chart
9,530x the last time this happened
Here's what our expert says you should buy before April 14.
Buy
62
BMRN
Biomarin Pharmaceutical
Last Price:
82.71
Seasonality Move:
6.56%
7 Day Trial
ALL ACCESS PASS
$
7
MarketBeat Alert: Strong sell signal just issued for these 20 stocks
Go here now to get free instant access to all 20 stocks to sell.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.
Biomarin Pharmaceutical Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 85.26 | Sell |
| 20-day SMA: | 87.88 | Sell |
| 50-day SMA: | 87.21 | Sell |
| 200-day SMA: | 89 | Sell |
| 8-day EMA: | 84.41 | Sell |
| 20-day EMA: | 86.47 | Sell |
| 50-day EMA: | 87.56 | Sell |
| 200-day EMA: | 89.47 | Sell |
Biomarin Pharmaceutical Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.32 | Sell |
| Relative Strength Index (14 RSI): | 41.12 | Sell |
| Chaikin Money Flow: | 1176715 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (84.33 - 91.21) | Sell |
| Bollinger Bands (100): | (85.71 - 94.59) | Sell |
Biomarin Pharmaceutical Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Biomarin Pharmaceutical Stock
Is Biomarin Pharmaceutical Stock a Buy?
- Biomarin Pharmaceutical share price is 83.33 while BMRN 8-day simple moving average is 85.26, which is a Sell signal.
- The stock price of BMRN is 83.33 while Biomarin Pharmaceutical 20-day SMA is 87.88, which makes it a Sell.
- Biomarin Pharmaceutical 50-day simple moving average is 87.21 while BMRN share price is 83.33, making it a Sell technically.
- BMRN stock price is 83.33 and Biomarin Pharmaceutical 200-day simple moving average is 89.00, creating a Sell signal.
BMRN Technical Analysis vs Fundamental Analysis
Buy
62
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy or a Sell?
-
Biomarin Pharmaceutical stock is rated a Buy
The current Biomarin Pharmaceutical [BMRN] share price is $83.33. The Score for BMRN is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
Biomarin Pharmaceutical Stock Info
Market Cap:
15.82B
Price in USD:
83.33
Share Volume:
1.88M
Biomarin Pharmaceutical 52-Week Range
52-Week High:
99.56
52-Week Low:
76.02
Buy
62
Biomarin Pharmaceutical (BMRN)
is a Buy
Biomarin Pharmaceutical Share Price Forecast
-
What is the Biomarin Pharmaceutical stock price today?
The Biomarin Pharmaceutical stock price is 83.33 USD today. -
Will BMRN stock go up or go down?
Biomarin Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators -
Is Biomarin Pharmaceutical overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Biomarin Pharmaceutical is not overvalued.
Is Biomarin Pharmaceutical Stock a Buy?
- Biomarin Pharmaceutical share price is 83.33 while BMRN 8-day exponential moving average is 84.41, which is a Sell signal.
- The stock price of BMRN is 83.33 while Biomarin Pharmaceutical 20-day EMA is 86.47, which makes it a Sell.
- Biomarin Pharmaceutical 50-day exponential moving average is 87.56 while BMRN share price is 83.33, making it a Sell technically.
- BMRN stock price is 83.33 and Biomarin Pharmaceutical 200-day simple moving average is 89.47, creating a Sell signal.
Fundamental Analysis of Biomarin Pharmaceutical
Is Biomarin Pharmaceutical a good investment?
- Analysts estimate an earnings increase this quarter of $0.26 per share, an increase next quarter of $0.09 per share, an increase this year of $0.83 per share, and an increase next year of $0.89 per share.
Technical Analysis of Biomarin Pharmaceutical
Should I short Biomarin Pharmaceutical stock?
- BMRN Moving Average Covergence Divergence (MACD) indicator is -1.32, suggesting Biomarin Pharmaceutical is a Sell
- Biomarin Pharmaceutical Relative Strength Index (RSI) is 41.12, which suggest Biomarin Pharmaceutical is oversold
- The Bollinger Bands (25) for Biomarin Pharmaceutical is (84.33 - 91.21), which suggest Biomarin Pharmaceutical is a Sell
- The Bollinger Bands (100) for Biomarin Pharmaceutical is (85.71 - 94.59), which suggest Biomarin Pharmaceutical is a Sell
* Biomarin Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.